CellsBin® Revenue

Biotechnology Research • New Haven, Connecticut, United States • 1-10 Employees

CellsBin® revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at CellsBin®

Rebecca Turk Macleod

Director of Technology

Company overview

Headquarters	101 College St, New Haven, Connecticut 06510, US
Website	cellsbin.com
NAICS	541714
Keywords	Artificial Intelligence, Cell Therapy, Nk Cell Therapy, Car-T Cell Therapy, Rare Cell Biology
Founded	2023
Employees	1-10
Socials

CellsBin® Email Formats

CellsBin® uses 1 email format. The most common is {first initial} (e.g., j@cellsbin.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@cellsbin.com	100%

About CellsBin®

CellsBin is a precision medicine tech-bio company leveraging AI and nanophotonics to precisely identify and characterize rare cells with unmatched sensitivity and scalability, advancing the development and efficacy of cell-based therapies. The CellsBin™ family of products is designed to evaluate the persistence and functional efficacy of therapy cells, as well as their impact on tumor burden, through simple blood tests, eliminating the need for invasive biopsies. Our recently launched product, CB-Scout™, monitors the persistence and functional efficacy of CAR-T and CAR-NK cells at concentrations as low as 1 in 10,000,000 (one thousand times more sensitive than flow cytometry) while providing functional insights beyond the reach of molecular methods like PCR. Coming next is CB™-Insight, designed to assess cell therapy efficacy by directly measuring tumor burden in blood.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

CellsBin® has never raised funding before.

Frequently asked questions

CellsBin® is located in New Haven, Connecticut, US.

CellsBin® generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

CellsBin® has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CellsBin® was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

CellsBin® has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at CellsBin®

Rebecca Turk Macleod

Director of Technology

4.8

40,000 users